Drug Trial Radar · NCT01845194
Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug Pharmacokinetics
Last checked: Nov 20, 2026Latest source record: Apr 21, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
117
Actual
Start
Dec 2009
Primary completion
Oct 2013
Study completion Oct 2013
Sponsor
- Lead sponsor
- Institut fuer anwendungsorientierte Forschung und klinische Studien GmbHAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 3, 2013
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Basic science
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This human pharmacokinetic study investigates, whether processes of drug metabolism and transport are determined by genetic or hereditary factors. Therefore, approved drugs are applied to twins and metabolism and transport processes are investigated.
Conditions
- Drug Biotransformation
- Membrane Transport
Interventions
CodeineDrug
Treatment period 2: 5 mg Codeine once
MidazolamDrug
Treatment period 1: 0.2 mg Midazolam 3x Treatment period 2: 1 mg Midazolam once
PravastatinDrug
Treatment period 2: 5 mg Pravastatin once
TorsemideDrug
Treatment period 1: 2.5 mg Torsemide 3x Treatment period 2: 0.25 mg Torsemide once
TalinololDrug
Treatment period 1: 50 mg Talinolol 3x Treatment period 2: 2.5 mg Talinolol once
CaffeineDrug
Treatment period 1: 50 mg Caffeine 3x
MetoprololDrug
Treatment period 1: 5 mg Metoprolol 3x
Primary outcomes
What the sponsor says the trial is designed to measure.
- plasma drug concentrationsTime frame: up to 24 h after drug application
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Dept. of Clinical Pharmacology, Georg-August-University of Goettingen
Göttingen, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.